Effects of Glucocorticoid on Human Dermal Papilla Cells In Vitro

    Soon‐Jin Choi, A‐Ri Cho, Seong Jin Jo, Sungjoo Hwang, Kyu Han Kim, Ohsang Kwon
    New to Vascular Endothelial Growth Factor? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that dexamethasone treatment reduced cell viability and growth factor expression in human dermal papilla cells, suggesting it inhibits hair growth. Our plain-language summary of this paper — not a Tressless recommendation.
    The study investigated the effects of the synthetic glucocorticoid dexamethasone (Dex) on human dermal papilla cells (hDPCs) in vitro, focusing on its impact on cell proliferation and growth factor expression. Dex treatment at a concentration of 1 μM significantly reduced the number of viable hDPCs and downregulated the expression of the Ki-67 protein, as well as growth factors VEGF and HGF. The findings suggested that Dex inhibited hair growth by inducing cell cycle arrest and decreasing cyclin D1 expression, highlighting the potential role of stress-induced glucocorticoids in hair loss.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results